MSD: Overall survival data are not mature, but it has been observed that Intismeran and Keytruda show an advantageous trend in terms of overall survival.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.